Phase II study of sintilimab combined with nab-paclitaxel in the treatment of platinum-resistant recurrent ovarian cancer.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Peking University Cancer Hospital
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162564646
Cites:
Cited by:
Related to: